<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>6(1)</volume><submitter>Patil G</submitter><funding>Council of Scientific and Industrial Research</funding><funding>Lady Tata Memorial Trust</funding><pubmed_abstract>Diabetes is one of the major risk factors for Alzheimer's disease (AD) development. The role of elevated levels of glucose, methylglyoxal (MGO), and advanced glycation end products (AGEs) in the pathogenesis of AD is not well understood. In this pursuit, we studied the role of methylglyoxal in the pathogenesis of AD in rat models. The elevated plus-maze (EPM) behavioral study indicated that MGO induces anxiety. Treatment of telmisartan (RAGE expression inhibitor) and aminoguanidine (MGO quencher) attenuated MGO induced anxiety. Further, hippocampal proteomics demonstrated that MGO treated rats differentially regulate proteins involved in calcium homeostasis, mitochondrial functioning, and apoptosis, which may affect neurotransmission and neuronal plasticity. The hippocampal tau phosphoryla</pubmed_abstract><journal>ACS pharmacology &amp; translational science</journal><pagination>65-75</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC9841776</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Behavioral and Proteomic Studies Reveal Methylglyoxal Activate Pathways Associated with Alzheimer's Disease.</pubmed_title><pmcid>PMC9841776</pmcid><pubmed_authors>Patil G</pubmed_authors><pubmed_authors>Kale V</pubmed_authors><pubmed_authors>Mote C</pubmed_authors><pubmed_authors>Kulsange S</pubmed_authors><pubmed_authors>Kulkarni M</pubmed_authors><pubmed_authors>Koratkar S</pubmed_authors><pubmed_authors>Chirmade T</pubmed_authors><pubmed_authors>Kazi R</pubmed_authors><pubmed_authors>Aswar M</pubmed_authors><pubmed_authors>Agawane S</pubmed_authors></additional><is_claimable>false</is_claimable><name>Behavioral and Proteomic Studies Reveal Methylglyoxal Activate Pathways Associated with Alzheimer's Disease.</name><description>Diabetes is one of the major risk factors for Alzheimer's disease (AD) development. The role of elevated levels of glucose, methylglyoxal (MGO), and advanced glycation end products (AGEs) in the pathogenesis of AD is not well understood. In this pursuit, we studied the role of methylglyoxal in the pathogenesis of AD in rat models. The elevated plus-maze (EPM) behavioral study indicated that MGO induces anxiety. Treatment of telmisartan (RAGE expression inhibitor) and aminoguanidine (MGO quencher) attenuated MGO induced anxiety. Further, hippocampal proteomics demonstrated that MGO treated rats differentially regulate proteins involved in calcium homeostasis, mitochondrial functioning, and apoptosis, which may affect neurotransmission and neuronal plasticity. The hippocampal tau phosphoryla</description><dates><release>2023-01-01T00:00:00Z</release><publication>2023 Jan</publication><modification>2026-05-27T11:08:39.841Z</modification><creation>2025-04-05T15:53:03.306Z</creation></dates><accession>S-EPMC9841776</accession><cross_references><pubmed>36654748</pubmed><doi>10.1021/acsptsci.2c00143</doi></cross_references></HashMap>